Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis Location: Phoenix, Arizona 8 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
PHASE4INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Pheonix, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type